Navigation

  • Skip to Content
  • Facebook
  • Linkedin
  • Instagram
  • Bluesky
  • Youtube
  • Spotify
  • X

Language Selector

  • ITA
  • ENG
Italian Medicines Agency

Italian Medicines Agency

Follow us on

  • Facebook
  • Linkedin
  • Instagram
  • Bluesky
  • Youtube
  • Spotify
  • X

Language Selector

  • ITA
  • ENG

Aifa toggle bar Search

 
 
 

Aifa toggle bar Search

  • The Agency
    • The Agency
    • Mission and values
    • Organisation
    • Scientific and Economic Committee for Medicines
    • Support and Coordination Secretariats and Advisory Committees
    • International Collaborations
    • EU Projects
    • Legislation
    • Forms
    • Competition notices
    • Resolutions
    • Tenders and contracts
    • Quality assurance
    • Guarantee Committee
    • Atti di notifica
    • Associazioni dei pazienti
    • AIFA Incontra
    • Contacts
    • Certified email
  • COVID-19
    • COVID-19
    • Communications about COVID-19
    • COVID-19 Vaccines
    • Medicines usable for treatment of COVID-19 disease
    • Use of monoclonal antibodies for COVID-19
    • Use of antivirals for COVID-19
    • Monitoring of medicinal products used during the COVID-19 epidemic
    • Clinical Trials - COVID-19
    • Compassionate Use Programs - COVID-19
  • Access to medicinal products
    • Access to medicinal products
    • Early access and off-label use
    • Authorisation of medicinal products
    • Medicine shortages
    • Antibiotic medicinal products
    • Biological medicinal products
    • Vaccines
    • Blood derivatives
    • Generic medicinal products
    • Biosimilar medicinal products
    • Orphan medicinal products
    • Advanced therapies
    • Homeopathic medicinal products
    • Allergens
    • Medicinali di origine vegetale
    • Ancillary medicinal substances incorporated in medical devices
  • Safety of medicinal products
    • Safety of medicinal products
    • Pharmacovigilance 
    • National Pharmacovigilance Network
    • Adverse Reactions to medicinal products
    • Persons in charge of Pharmacovigilance
    • European Eudravigilance System
    • Accesso alle segnalazioni - ADRreports
    • Regional pharmacovigilance funds
    • Segnali di sicurezza
    • Risk management measures
    • Medicinal products subject to additional monitoring
  • Quality and Inspections
    • Quality and Inspections
    • Quality defects
    • Inspections and authorisations
    • Qualified person
    • Fight of pharmaceutical crime
  • Research and Clinical trials
    • Research and Clinical trials
    • Clinical trials concerning medicinal products
    • EU Regulation on Clinical trials
    • National Observatory on Clinical Trials
    • Registro Studi Osservazionali
    • Comitati Etici Nazionali (CEN)
    • Ethics Committees Coordination Centre
    • Independent clinical research
    • Mappa dei centri di Sperimentazione Clinica
  • Pricing and reimbursement
    • Pricing and reimbursement
    • Negotiation and reimbursement
    • Economic evaluations
    • Monitoring Registers
    • AIFA Notes
    • Lists of Class A and Class H medicinal products
    • Innovative medicinal products
    • Transparency Lists
  • Consumption and pharmaceutical expenditure
    • Consumption and pharmaceutical expenditure
    • The Medicines Utilization Monitoring Centre (OsMed) 
    • Governance of pharmaceutical expenditure
    • Monitoring pharmaceutical expenditure
  • Innovation and planning
    • Innovation and planning
    • Innovation and scientific advice
    • Horizon scanning
  • Information and communication
    • Information and communication
    • FarmaciLine
    • Medical and scientific information
    • FAQ
    • Publications
    • Communication campaigns
    • Eventi AIFA
    • Scientific Seminars
    • Press releases
    • Dossier AIFA
    • Mobile APP AIFA
    • APP Firstline AIFA - Antibiotici
    • ABC della Ricerca Clinica
    • Presentations and speeches
    • Public consultations and documents
    • Documents shared with scientific communities 
    • Calendario eventi
    • Archivio
  • AIFA data
    • AIFA data
    • OsMed Data
    • Open Data
  • Companies Section
    • Companies Section
    • Requests for authorisation of conferences and meetings
    • Payment of fees and annual duties
    • MA Electronic invoicing
    • Application for reimbursement and pricing
    • Access information
    • Notifica concessionari di vendita
    • Comunicazione prima commercializzazione
  • Open governance
    • Open governance
    • Disposizioni Generali
    • Organizzazione
    • Consulenti e collaboratori
    • Personale
    • Bandi di Concorso
    • Performance
    • Enti controllati
    • Attività e procedimenti
    • Provvedimenti
    • Bandi di gara e contratti
    • Sovvenzioni, contributi, sussidi, vantaggi economici
    • Bilanci
    • Beni immobili e gestione patrimonio
    • Controlli e rilievi sull'Amministrazione
    • Servizi Erogati
    • Pagamenti dell'Amministrazione
    • Opere pubbliche
    • Pianificazione e governo del territorio
    • Informazioni ambientali
    • Interventi straordinari di emergenza
    • Altri Contenuti
Italian Medicines Agency Agenzia Italiana del Farmaco

2019

Breadcrumb

  • home
  • Pricing and reimbursement
  • Monitoring Registers
  • Registry archive
  • 2019

Archivio Registri 2019

09/05/2019

Attivazione Registro JAKAVI (Policitemia vera)

13/05/2019

Registri AIFA: l'Agenzia fornisce informazioni sui dati dei trattamenti con i nuovi farmaci per la cura dell’epatite C

16/05/2019

Attivazione Registro ZEJULA

17/05/2019

Pubblicazione schede di monitoraggio e attivazione Registri - PT METILFENIDATO e ATOMOXETINA

17/05/2019

Attivazione Registro ORKAMBI

21/05/2019

Attivazione Registro BENLYSTA

21/05/2019

Attivazione Registro GAZYVARO (LF)

23/05/2019

Registro ORKAMBI - Modalità operative per la compilazione

24/05/2019

Attivazione Registro JINARC

28/05/2019

Implementazione posologia PT XARELTO (indicazione TVP - EP)

28/05/2019

Attivazione Registro STIVARGA (HCC)

28/05/2019

Attivazione Registro VENCLYXTO

28/05/2019

Attivazione Registro OPDIVO (cHL)

30/05/2019

Informazioni per l’utilizzo dei PT web AIFA - metilfenidato e atomoxetina

30/05/2019

Attivazione Registro OPDIVO (ca. testa – collo)

All news

Page 7 of 12
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
— 15 Items per Page
Showing 91 - 105 of 170 results.
  • ← First
  • Previous
  • Next
  • Last →

Site Map

Pricing and reimbursement
  • Negotiation and reimbursement
  • Economic evaluations
  • Monitoring Registers
    • Access to system
    • Health facilities authorised by regional approvers
    • AIFA Registries
    • Analysis of monitoring registries
    • Update on hepatitis C
    • Registry archive
  • AIFA Notes
  • Lists of Class A and Class H medicinal products
  • Innovative medicinal products
  • Transparency Lists

Share

Site Map

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • Comunicazioni Managed Entry Agreements (MEA)

Cookie Bar

cookie management module

close and reject everything

Descrizione cookieBar

Questo sito utilizza cookie tecnici e analytics, necessari al suo funzionamento, per i quali non è richiesto il consenso. Per alcuni servizi aggiuntivi, le terze parti fornitrici, dettagliatamente sotto individuate, possono utilizzare cookies tecnici, analytics e di profilazione. Per saperne di più consulta la PRIVACY POLICY. Per proseguire nella navigazione devi effettuare la scelta sui cookie di terze parti dei quali eventualmente accetti l’utilizzo. Chiudendo il banner attraverso la X in alto a destra rifiuti tutti i cookie di terze parti. Puoi rivedere e modificare le tue scelte in qualsiasi momento attraverso il link "Gestione cookie" presente nel footer.

Social networks

Footer

agenzia Italiana del Farmaco

The agency

  • Home Page
  • FarmaciLine
  • User participation and satisfaction
  • Citizens' access
  • Modulistica
  • Open governance
  • Acts of notification
  • Legal notification
  • TrovaNormeFarmaco
  • Competition notices
  • Tenders and contracts

Contacts

Via del Tritone, 181 00187 Roma

  • Contacts
  • Certified e-mail (PEC) contacts

VAT number: 08703841000

Tax code: 97345810580

IPA AIFA code: aifa_rm

IPA UCB code: UFE1TR

FOLLOW US ON

  • Facebook
  • Linkedin
  • label.button.spotify
  • Bluesky
  • Youtube
  • Linkedin

FEED RSS

  • Feed Rss

COOKIES

  • Cookie management

Sezione Link Utili

  • Legal notice
  • Social Media Policy
  • Dichiarazione di accessibilità
  • Web accessibility
  • Website statistics
  • Privacy
  • Online services
go to beginning of content